AACR StoriesThe Faces & Voices Behind the Science
Ancestry-informed biology and precision treatment are helping to change the game for patients with prostate cancer.
Decades of pioneering research led to a first-of-its-kind FDA approval for a new type of immunotherapy—tumor-infiltrating lymphocyte (TIL) therapy.
Learn MoreLaunched in 2015, AACR Project GENIE® is powering advances in cancer precision medicine through an international collaboration of top cancer centers that are sharing data for all to access.
Learn MoreUsing funding from the AACR, early-career investigator Marco Ruella, MD, found a way to improve immunotherapy for B-cell acute lymphoblastic leukemia.
Learn MoreChemtai Mungo is researching an innovative self-treatment strategy for cervical precancer could save lives of women in underserved areas.
Your donation to the American Association for Cancer Research helps our more than 61,000 members worldwide drive progress against cancer.
Donate Now
